2016
DOI: 10.1007/s13410-016-0536-z
|View full text |Cite
|
Sign up to set email alerts
|

Mortality and natural progression of type 1 diabetes patients enrolled in the Rwanda LFAC program from 2004 to 2012

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
16
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(19 citation statements)
references
References 19 publications
3
16
0
Order By: Relevance
“…16,40 The Mali study population also had a younger age of death and shorter duration of diabetes prior to death compared to research from Rwanda, where mean age at death was 19.4 years and duration of diabetes 4.1 years. 15 The increasing known incidence and lower mortality combined to sharply increase prevalence at all ages. It is likely that prevalence will continue to rise with the reduction in mortality.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…16,40 The Mali study population also had a younger age of death and shorter duration of diabetes prior to death compared to research from Rwanda, where mean age at death was 19.4 years and duration of diabetes 4.1 years. 15 The increasing known incidence and lower mortality combined to sharply increase prevalence at all ages. It is likely that prevalence will continue to rise with the reduction in mortality.…”
Section: Discussionmentioning
confidence: 99%
“…control and a high rate of complications and premature death from diabetes. 6,[12][13][14][15][16][17] In 2007, the French non-government organization Santé Diabète (which has a full time delegation in Mali) and the Life for a Child program (LFAC), commenced an intervention to provide care for all young people <26 years of age with diabetes in Mali. Before this, very limited care was available, and most children and youth with diabetes in Mali died within a couple of years of diagnosis.…”
mentioning
confidence: 99%
“…Even with accurate diagnosis, mortality has been high in studies in sub-Saharan Africa[ 26 - 28 ], but there are indications it is falling - for instance in Rwanda it was found to be between 13.9-40.2 per 1000 patient years, depending on the fate of those lost to follow-up[ 29 ]. The figure of 32/1000 from this study is in this range - and in Rwanda like in Ghana, care is improving as supplies are made available[ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…Even with accurate diagnosis, mortality has been high in studies in sub-Saharan Africa [26][27][28] , but there are indications it is falling -for instance in Rwanda it was found to be between 13.9-40.2 per 1000 patient years, depending on the fate of those lost to follow-up [29] . The figure of 32/1000 from this study is in this range -and in Rwanda like in Ghana, care is improving as supplies are made available [30] .…”
Section: Discussionmentioning
confidence: 99%